A single course of rituximab does not abrogate anti-infliximab antibodies in patients with rheumatoid arthritis

Ann Rheum Dis. 2009 Aug;68(8):1368-9. doi: 10.1136/ard.2008.095448.
No abstract available

Publication types

  • Controlled Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Aged
  • Antibodies / blood*
  • Antibodies, Monoclonal / immunology*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / drug therapy*
  • Female
  • Humans
  • Infliximab
  • Male
  • Middle Aged
  • Rituximab

Substances

  • Antibodies
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antirheumatic Agents
  • Rituximab
  • Infliximab